Arkolith/Insider Trading/IMVT/Form 4

Geffner Michael

Chief Medical OfficerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Oct 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$49K
Net Open-Market Flow
-$49K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 22, 2025Sell(S)3K$19.03$49K218K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-25-000144) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML